Weight-loss drugs like Ozempic, developed by Novo Nordisk, have been shown in a new study to potentially reduce rates of opioid and alcohol abuse by up to 50%. The study suggests that these medications may provide additional benefits beyond weight loss and diabetes management, offering hope for addressing substance abuse issues. This research supports the idea that weight-loss drugs could play a significant role in improving overall health outcomes beyond their primary intended use.
Full Article
Why Britain needs a digital ID system
Roula Khalaf, Editor of the FT, highlights the potential benefits of implementing a digital identity system in Britain, citing examples from countries like Estonia, Australia, Singapore, and Italy. The system could streamline public services, reduce fraud, and improve tax collection, although there are concerns about data privacy and technology challenges. Despite opposition and past failures, proponents argue that a well-designed digital ID could enhance efficiency, security, and economic gains for the UK. Full Article
Read more